A novel mechanism for imatinib mesylate–induced cell death of BCR-ABL–positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity — Masayuki Okada (2003) | RDL Network
A novel mechanism for imatinib mesylate–induced cell death of BCR-ABL–positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity
Mads Gyrd‐Hansen, Thomas Farkas, Nicole Fehrenbacher, Lone Bastholm, Maria Høyer-Hansen, Folmer Elling, David Wallach, Richard A. Flavell, Guido Guido Kroemer, Jesper Nylandsted, Marja Jäättelä
Discussion(0)
No comments yet. Be the first to comment.